<?xml version="1.0" encoding="ISO-8859-1"?><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<front>
<journal-meta>
<journal-id>2301-1254</journal-id>
<journal-title><![CDATA[Anales de la Facultad de Medicina]]></journal-title>
<abbrev-journal-title><![CDATA[Anfamed]]></abbrev-journal-title>
<issn>2301-1254</issn>
<publisher>
<publisher-name><![CDATA[Universidad de la República. Facultad de Medicina]]></publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id>S2301-12542025000101204</article-id>
<article-id pub-id-type="doi">10.25184/anfamed2025v12n1a7</article-id>
<title-group>
<article-title xml:lang="es"><![CDATA[Oncología en el interior del país. Experiencia en un Centro Docente Asociado de Rivera.]]></article-title>
<article-title xml:lang="en"><![CDATA[Oncology Outside the Capital: Experience at the Rivera Teaching Center]]></article-title>
<article-title xml:lang="pt"><![CDATA[Oncologia no interior do país: Experiência no Centro Docente Associado de Rivera.]]></article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Camejo]]></surname>
<given-names><![CDATA[Natalia]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Rondan]]></surname>
<given-names><![CDATA[Monika]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Castillo]]></surname>
<given-names><![CDATA[Cecilia]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Krygier]]></surname>
<given-names><![CDATA[Gabriel]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
</contrib-group>
<aff id="Af1">
<institution><![CDATA[,Universidad de la República Hospital de Clínicas Servicio de Oncología Clínica]]></institution>
<addr-line><![CDATA[Montevideo ]]></addr-line>
<country>Uruguay</country>
</aff>
<aff id="Af2">
<institution><![CDATA[,Cooperativa Médica de Rivera (COMERI  ]]></institution>
<addr-line><![CDATA[ ]]></addr-line>
</aff>
<pub-date pub-type="pub">
<day>00</day>
<month>00</month>
<year>2025</year>
</pub-date>
<pub-date pub-type="epub">
<day>00</day>
<month>00</month>
<year>2025</year>
</pub-date>
<volume>12</volume>
<numero>1</numero>
<copyright-statement/>
<copyright-year/>
<self-uri xlink:href="http://www.scielo.edu.uy/scielo.php?script=sci_arttext&amp;pid=S2301-12542025000101204&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.edu.uy/scielo.php?script=sci_abstract&amp;pid=S2301-12542025000101204&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.edu.uy/scielo.php?script=sci_pdf&amp;pid=S2301-12542025000101204&amp;lng=en&amp;nrm=iso"></self-uri><abstract abstract-type="short" xml:lang="es"><p><![CDATA[Resumen  Introducción: El cáncer es una de las principales causas de muerte en nuestro país. Los cánceres de mama, próstata, pulmón y colorrecto abarcan aproximadamente la mitad de los casos presentes en el país. En el departamento de Rivera, la incidencia de cáncer en hombres y mujeres durante el periodo 2016-2020 mostró altos valores de cáncer de próstata y de mama.  Objetivo: Describir y analizar el perfil clínico-epidemiológico de los pacientes asistidos en el Sanatorio COMERI, Rivera, durante el período 2015-2022.  Materiales y métodos: Estudio observacional, retrospectivo, que incluyó pacientes portadores de cáncer asistidos en el Sanatorio COMERI de la ciudad de Rivera, en el periodo 2015 - 2022.  Resultados: Se incluyeron 254 pacientes, 130 eran mujeres con una mediana de edad de 63 años, mientras que para los hombres fue 66 años. Los tumores más frecuentes fueron mama (25%), colorrecto (16%) y próstata (13%). Con respecto a los criterios de tratamiento, de los pacientes con tumores EI-III, 16% permanecieron en control exclusivo, 6% recibieron tratamiento neoadyuvante, 42% tratamiento adyuvante y 22% tratamiento radical. De los pacientes con tumores EIV 12% recibieron tratamiento oncoespecífico y 2% tratamiento sintomático paliativo. El tiempo entre el diagnóstico y el primer tratamiento oncológico fue &#8804; 2 meses para el 70% de los pacientes y para el 30% restante fue &#8804; 3 meses. El 20% de los pacientes fue discutido en Comité de Tumores. Todos los pacientes con enfermedad diseminada, fueron encaminados a seguimiento en conjunto con UCP.  Conclusiones: El cáncer es un problema de salud importante en Uruguay. Los datos obtenidos en este estudio pueden ayudar a planificar mejoras en infraestructura, logística, equipamiento y personal de salud, optimizando así la calidad del servicio brindado en el Sanatorio COMERI.]]></p></abstract>
<abstract abstract-type="short" xml:lang="en"><p><![CDATA[Abstract  Introduction:  Cancer is one of the leading causes of death in our country. Breast, prostate, lung, and colorectal cancers account for approximately half of the cancer cases in the country. In the department of Rivera, the incidence of cancer in both men and women during the period 2016-2020 showed high values for prostate and breast cancer. Objective: To describe and analyze the clinical-epidemiological profile of patients treated at the COMERI Sanatorium, Rivera, during the period 2015-2022.  Materials and Methods:  Observational, retrospective study that included cancer patients treated at the COMERI Sanatorium in the city of Rivera, during the period 2015-2022.  Results:  A total of 254 patients were included, 130 were women with a median age of 63 years, while for men it was 66 years. The most common tumors were breast (25%), colorectal (16%), and prostate (13%). Regarding treatment criteria, among patients with stage I-III tumors, 16% remained under exclusive monitoring, 6% received neoadjuvant treatment, 42% received adjuvant treatment, and 22% underwent radical treatment. Of the patients with stage IV tumors, 12% received tumor-specific treatment and 2% received symptomatic palliative care. The time between diagnosis and the first oncological treatment was &#8804; 2 months for 70% of patients, and &#8804; 3 months for the remaining 30%. Twenty percent of patients were discussed in Tumor Board meetings. All patients with disseminated disease were referred for follow-up in conjunction with the Palliative Care Unit (PCU).  Conclusions:  Cancer is a major health issue in Uruguay. The data obtained from this study can assist in planning improvements in infrastructure, logistics, equipment, and healthcare personnel, thereby optimizing the quality of services provided at the COMERI Sanatorium.]]></p></abstract>
<abstract abstract-type="short" xml:lang="pt"><p><![CDATA[Resumo  Introdução:  O câncer é uma das principais causas de morte em nosso país. Os cânceres de mama, próstata, pulmão e colorretal representam aproximadamente metade dos casos no país. No departamento de Rivera, a incidência de câncer em homens e mulheres durante o período de 2016-2020 mostrou altos valores de câncer de próstata e mama. Objetivo: Descrever e analisar o perfil clínico-epidemiológico dos pacientes atendidos no Sanatório COMERI, Rivera, durante o período de 2015-2022.  Materiais e métodos:  Estudo observacional, retrospectivo, que incluiu pacientes com diagnóstico de câncer atendidos no Sanatório COMERI da cidade de Rivera, no período de 2015 - 2022.  Resultados:  Foram incluídos 254 pacientes, sendo 130 mulheres com mediana de idade de 63 anos, enquanto para os homens foi de 66 anos. Os tumores mais frequentes foram mama (25%), colorretal (16%) e próstata (13%). Quanto aos critérios de tratamento, entre os pacientes com tumores em estádios I-III, 16% permaneceram em controle exclusivo, 6% receberam tratamento neoadjuvante, 42% tratamento adjuvante e 22% tratamento radical. Entre os pacientes com tumores em estádio IV, 12% receberam tratamento oncoespecífico e 2% tratamento sintomático paliativo. O tempo entre o diagnóstico e o primeiro tratamento oncológico foi &#8804; 2 meses para 70% dos pacientes, enquanto para os 30% restantes foi &#8804; 3 meses. 20% dos pacientes foram discutidos em Comitê de Tumores. Todos os pacientes com doença disseminada foram encaminhados para acompanhamento conjunto com a UCP.  Conclusões:  O câncer é um problema importante de saúde no Uruguai. Os dados obtidos neste estudo podem ajudar a planejar melhorias em infraestrutura, logística, equipamentos e recursos humanos, otimizando assim a qualidade do serviço oferecido no Sanatório COMERI.]]></p></abstract>
<kwd-group>
<kwd lng="es"><![CDATA[Epidemiología]]></kwd>
<kwd lng="es"><![CDATA[Neoplasmas]]></kwd>
<kwd lng="es"><![CDATA[Características clínico-patológicas]]></kwd>
<kwd lng="en"><![CDATA[Epidemiology]]></kwd>
<kwd lng="en"><![CDATA[Neoplasms]]></kwd>
<kwd lng="en"><![CDATA[Clinicopathological features]]></kwd>
<kwd lng="pt"><![CDATA[Epidemiologia]]></kwd>
<kwd lng="pt"><![CDATA[Neoplasias]]></kwd>
<kwd lng="pt"><![CDATA[Características clínico-patológicas]]></kwd>
</kwd-group>
</article-meta>
</front><back>
<ref-list>
<ref id="B1">
<label>1</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Barrios]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Garau]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Cáncer: Magnitud del problema en el mundo y en Uruguay, aspectos epidemiológicos]]></article-title>
<source><![CDATA[Anales de la Facultad de Medicina]]></source>
<year>2017</year>
<volume>4</volume>
<page-range>9-46</page-range></nlm-citation>
</ref>
<ref id="B2">
<label>2</label><nlm-citation citation-type="">
<collab>CHLCC</collab>
<source><![CDATA[Resumen Estadístico - INCIDENCIA - Promedio Casos por Departamento - HOMBRES. 2016-2020]]></source>
<year></year>
</nlm-citation>
</ref>
<ref id="B3">
<label>3</label><nlm-citation citation-type="">
<collab>CHLCC</collab>
<source><![CDATA[Resumen Estadístico - INCIDENCIA - Promedio Casos por Departamento - MUJERES. 2016-2020]]></source>
<year></year>
</nlm-citation>
</ref>
<ref id="B4">
<label>4</label><nlm-citation citation-type="">
<collab>CHLCC</collab>
<source><![CDATA[MORTALIDAD - Promedio Casos por Departamento - HOMBRES. 2016-2020]]></source>
<year></year>
</nlm-citation>
</ref>
<ref id="B5">
<label>5</label><nlm-citation citation-type="">
<collab>CHLCC</collab>
<source><![CDATA[MORTALIDAD - Promedio Casos por Departamento - MUJERES. 2016-2020]]></source>
<year></year>
</nlm-citation>
</ref>
<ref id="B6">
<label>6</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Desch]]></surname>
<given-names><![CDATA[CE]]></given-names>
</name>
<name>
<surname><![CDATA[McNiff]]></surname>
<given-names><![CDATA[KK]]></given-names>
</name>
<name>
<surname><![CDATA[Schneider]]></surname>
<given-names><![CDATA[EC]]></given-names>
</name>
<name>
<surname><![CDATA[Schrag]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[McClure]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Lepisto]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[American Society of Clinical Oncology/National Comprehensive Cancer Network Quality Measures]]></article-title>
<source><![CDATA[J Clin Oncol]]></source>
<year>2008</year>
<volume>26</volume>
<numero>21</numero>
<issue>21</issue>
<page-range>3631-7</page-range></nlm-citation>
</ref>
<ref id="B7">
<label>7</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Malin]]></surname>
<given-names><![CDATA[JL]]></given-names>
</name>
<name>
<surname><![CDATA[Schneider]]></surname>
<given-names><![CDATA[EC]]></given-names>
</name>
<name>
<surname><![CDATA[Epstein]]></surname>
<given-names><![CDATA[AM]]></given-names>
</name>
<name>
<surname><![CDATA[Adams]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Emanuel]]></surname>
<given-names><![CDATA[EJ]]></given-names>
</name>
<name>
<surname><![CDATA[Kahn]]></surname>
<given-names><![CDATA[KL]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Results of the National Initiative for Cancer Care Quality how can we improve the quality of cancer care in the United States?]]></article-title>
<source><![CDATA[J Clin Oncol]]></source>
<year>2006</year>
<volume>24</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>626-34</page-range></nlm-citation>
</ref>
<ref id="B8">
<label>8</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Blayney]]></surname>
<given-names><![CDATA[DW]]></given-names>
</name>
<name>
<surname><![CDATA[McNiff]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
<name>
<surname><![CDATA[Hanauer]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Miela]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Markstrom]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Neuss]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Implementation of the Quality Oncology Practice Initiative at a university comprehensive cancer center]]></article-title>
<source><![CDATA[J Clin Oncol]]></source>
<year>2009</year>
<volume>27</volume>
<numero>23</numero>
<issue>23</issue>
<page-range>3802-7</page-range></nlm-citation>
</ref>
<ref id="B9">
<label>9</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Buchheit]]></surname>
<given-names><![CDATA[JT]]></given-names>
</name>
<name>
<surname><![CDATA[Silver]]></surname>
<given-names><![CDATA[CM]]></given-names>
</name>
<name>
<surname><![CDATA[Huang]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Hu]]></surname>
<given-names><![CDATA[YY]]></given-names>
</name>
<name>
<surname><![CDATA[Bentrem]]></surname>
<given-names><![CDATA[DJ]]></given-names>
</name>
<name>
<surname><![CDATA[Odell]]></surname>
<given-names><![CDATA[DD]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Association Between Racial and Socioeconomic Disparities and Hospital Performance in Treatment and Outcomes for Patients with Colon Cancer]]></article-title>
<source><![CDATA[Ann Surg Oncol]]></source>
<year>2024</year>
<volume>31</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>1075-86</page-range></nlm-citation>
</ref>
<ref id="B10">
<label>10</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Tibi]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Tieu]]></surname>
<given-names><![CDATA[V]]></given-names>
</name>
<name>
<surname><![CDATA[Babayigit]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Ling]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Influence of Health Insurance Types on Clinical Cancer Care Accessibility and Quality Using All of Us Database]]></article-title>
<source><![CDATA[Medicina (Kaunas)]]></source>
<year>2024</year>
<volume>60</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>623</page-range></nlm-citation>
</ref>
<ref id="B11">
<label>11</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Heeg]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Association between initiation of adjuvant chemotherapy beyond 30 days after surgery and overall survival among patients with triple-negative breast cancer]]></article-title>
<collab>Marang-van de Mheen PJ.Van Maaren MC.Schreuder K.Tollenaar RAEM.Siesling S</collab>
<source><![CDATA[Int J Cancer]]></source>
<year>2020</year>
<volume>147</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>152-9</page-range></nlm-citation>
</ref>
<ref id="B12">
<label>12</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Cheng]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
<name>
<surname><![CDATA[Chen]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Jia]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Liang]]></surname>
<given-names><![CDATA[Y]]></given-names>
</name>
<name>
<surname><![CDATA[Li]]></surname>
<given-names><![CDATA[Y]]></given-names>
</name>
<name>
<surname><![CDATA[Chen]]></surname>
<given-names><![CDATA[Y]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Determining the optimal timing of adjuvant chemotherapy initiation after concurrent chemoradiotherapy in locoregionally advanced nasopharyngeal carcinoma]]></article-title>
<source><![CDATA[ESMO Open]]></source>
<year>2024</year>
<volume>9</volume>
<numero>9</numero>
<issue>9</issue>
<page-range>103707</page-range></nlm-citation>
</ref>
<ref id="B13">
<label>13</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Amin]]></surname>
<given-names><![CDATA[MB]]></given-names>
</name>
<name>
<surname><![CDATA[Edge]]></surname>
<given-names><![CDATA[SB]]></given-names>
</name>
<name>
<surname><![CDATA[Greene]]></surname>
<given-names><![CDATA[FL]]></given-names>
</name>
</person-group>
<collab>eds</collab>
<source><![CDATA[AJCC Cancer Staging Manual]]></source>
<year>2017</year>
<edition>8</edition>
<publisher-loc><![CDATA[New York ]]></publisher-loc>
<publisher-name><![CDATA[Springer]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B14">
<label>14</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Basso]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Lustemberg]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Quian]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Rosa]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Echevarría]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<source><![CDATA[Guía de Práctica Clínica de Detección Temprana del Cáncer de Mama]]></source>
<year>2015</year>
<page-range>9-27</page-range><publisher-name><![CDATA[Minist Salud Pública República Orient del Uruguay]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B15">
<label>15</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Basso]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Lustemberg]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Quian]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Rosa]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Ruocco]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
<name>
<surname><![CDATA[Brescia]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<source><![CDATA[Guía de Práctica Clínica de Tamizaje del Cáncer Colo-rectal]]></source>
<year>2018</year>
<publisher-name><![CDATA[Ministerio de Salud Pública, República Oriental del Uruguay]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B16">
<label>16</label><nlm-citation citation-type="">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Muniz]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Briozzo]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Sicca]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Brescia]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Clavell]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Gallo]]></surname>
<given-names><![CDATA[LE]]></given-names>
</name>
</person-group>
<source><![CDATA[Guía de Práctica Clínica de Tamizaje de Cáncer de Cuello de Útero. Ministerio de Salud Pública, República Oriental del Uruguay]]></source>
<year>2014</year>
</nlm-citation>
</ref>
<ref id="B17">
<label>17</label><nlm-citation citation-type="">
<source><![CDATA[Encuesta Mundial de Tabaquismo en Adultos (GATS) 2017, Uruguay, Ministerio de Salud Pública e Instituto Nacional de Estadística]]></source>
<year>2017</year>
</nlm-citation>
</ref>
<ref id="B18">
<label>18</label><nlm-citation citation-type="">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Boado]]></surname>
<given-names><![CDATA[M.]]></given-names>
</name>
<name>
<surname><![CDATA[Ramos]]></surname>
<given-names><![CDATA[A.]]></given-names>
</name>
<name>
<surname><![CDATA[Bianco]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
</person-group>
<source><![CDATA[Estudio Nacional de Prevalencia de Tabaquismo en Uruguay. CIET]]></source>
<year>2008</year>
</nlm-citation>
</ref>
<ref id="B19">
<label>19</label><nlm-citation citation-type="">
<source><![CDATA[Encuesta Mundial sobre Tabaco en Jóvenes (GYTS) 2019, Uruguay, Observatorio Uruguayo de Drogas, Ministerio de Salud Pública. Encuesta Mundial sobre Tabaco en Jóvenes (GYTS) - Informe final]]></source>
<year>2019</year>
</nlm-citation>
</ref>
<ref id="B20">
<label>20</label><nlm-citation citation-type="">
<collab>Ministerio de Salud Pública Dirección General de la Salud, División Epidemiología</collab>
<source><![CDATA[2a Encuesta Nacional de Factores de Riesgo de Enfermedades Crónicas No Transmisibles]]></source>
<year></year>
</nlm-citation>
</ref>
<ref id="B21">
<label>21</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Rock]]></surname>
<given-names><![CDATA[CL]]></given-names>
</name>
<name>
<surname><![CDATA[Thomson]]></surname>
<given-names><![CDATA[CA]]></given-names>
</name>
<name>
<surname><![CDATA[Sullivan]]></surname>
<given-names><![CDATA[KR]]></given-names>
</name>
<name>
<surname><![CDATA[Howe]]></surname>
<given-names><![CDATA[CL]]></given-names>
</name>
<name>
<surname><![CDATA[Kushi]]></surname>
<given-names><![CDATA[LH]]></given-names>
</name>
<name>
<surname><![CDATA[Caan]]></surname>
<given-names><![CDATA[BJ]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[American Cancer Society nutrition and physical activity guideline for cancer survivors]]></article-title>
<source><![CDATA[CA Cancer J Clin]]></source>
<year>2022</year>
<volume>72</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>230-62</page-range></nlm-citation>
</ref>
<ref id="B22">
<label>22</label><nlm-citation citation-type="">
<collab>American Society of Clinical Oncology</collab>
<source><![CDATA[Quality Oncology Practice Initiative QOPI(r) Certification Program Standards. ASCO, 2020. Basado en los estándares de administración de quimioterapia de ASCO/ONS de 2016]]></source>
<year></year>
</nlm-citation>
</ref>
<ref id="B23">
<label>23</label><nlm-citation citation-type="book">
<collab>NICE</collab>
<source><![CDATA[Quality standard for suspected cancer (QS124)]]></source>
<year>2017</year>
<publisher-name><![CDATA[NICE]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B24">
<label>24</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Neuss]]></surname>
<given-names><![CDATA[MN]]></given-names>
</name>
<name>
<surname><![CDATA[Desch]]></surname>
<given-names><![CDATA[CE]]></given-names>
</name>
<name>
<surname><![CDATA[McNiff]]></surname>
<given-names><![CDATA[KK]]></given-names>
</name>
<name>
<surname><![CDATA[Eisenberg]]></surname>
<given-names><![CDATA[PD]]></given-names>
</name>
<name>
<surname><![CDATA[Gesme]]></surname>
<given-names><![CDATA[DH]]></given-names>
</name>
<name>
<surname><![CDATA[Jacobson]]></surname>
<given-names><![CDATA[JO]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[A process for measuring the quality of cancer care the Quality Oncology Practice Initiative]]></article-title>
<source><![CDATA[J Clin Oncol]]></source>
<year>2005</year>
<volume>23</volume>
<numero>25</numero>
<issue>25</issue>
<page-range>6233-9</page-range></nlm-citation>
</ref>
<ref id="B25">
<label>25</label><nlm-citation citation-type="">
<collab>CHLCC</collab>
<source><![CDATA[Resumen Estadístico - TODOS LOS CÁNCERES excepto PNM. Incidencia y Mortalidad periodo 2016-2020. Tendencia de la Mortalidad hasta 2021]]></source>
<year></year>
</nlm-citation>
</ref>
<ref id="B26">
<label>26</label><nlm-citation citation-type="">
<collab>Comisión Honoraria de Lucha Contra el Cáncer</collab>
<source><![CDATA[Incidencia - Tasas Ajustadas por Departamento - HOMBRES, 2016-2020]]></source>
<year></year>
</nlm-citation>
</ref>
<ref id="B27">
<label>27</label><nlm-citation citation-type="">
<collab>Comisión Honoraria de Lucha Contra el Cáncer</collab>
<source><![CDATA[Incidencia - Tasas Ajustadas por Departamento - MUJERES, 2016-2020]]></source>
<year></year>
</nlm-citation>
</ref>
<ref id="B28">
<label>28</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Garau]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Musetti]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Alonso]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Barrios]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Estadio, perfil biológico y tendencias de incidencia y mortalidad de cáncer de mama en Uruguay: Análisis por franjas etarias]]></article-title>
<source><![CDATA[Rev. Méd. Urug]]></source>
<year>2024</year>
<volume>40</volume>
<numero>1</numero>
<issue>1</issue>
</nlm-citation>
</ref>
<ref id="B29">
<label>29</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Llera]]></surname>
<given-names><![CDATA[AS]]></given-names>
</name>
<name>
<surname><![CDATA[Abdelhay]]></surname>
<given-names><![CDATA[ESFW]]></given-names>
</name>
<name>
<surname><![CDATA[Artagaveytia]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
<name>
<surname><![CDATA[Daneri-Navarro]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Müller]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
<name>
<surname><![CDATA[Velazquez]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[The Transcriptomic Portrait of Locally Advanced Breast Cancer and Its Prognostic Value in a Multi-Country Cohort of Latin American Patients]]></article-title>
<source><![CDATA[Front Oncol]]></source>
<year>2022</year>
<volume>12</volume>
<page-range>835626</page-range></nlm-citation>
</ref>
<ref id="B30">
<label>30</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Del Turco]]></surname>
<given-names><![CDATA[MR]]></given-names>
</name>
<name>
<surname><![CDATA[Ponti]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Bick]]></surname>
<given-names><![CDATA[U]]></given-names>
</name>
<name>
<surname><![CDATA[Biganzoli]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Cserni]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Cutuli]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Quality indicators in breast cancer care]]></article-title>
<source><![CDATA[Eur J Cancer]]></source>
<year>2010</year>
<volume>46</volume>
<numero>13</numero>
<issue>13</issue>
<page-range>2344-56</page-range></nlm-citation>
</ref>
<ref id="B31">
<label>31</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Rubio]]></surname>
<given-names><![CDATA[IT]]></given-names>
</name>
<name>
<surname><![CDATA[Marotti]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Biganzoli]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Aristei]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Athanasiou]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Campbell]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[EUSOMA quality indicators for non-metastatic breast cancer An update]]></article-title>
<source><![CDATA[Eur J Cancer]]></source>
<year>2024</year>
<volume>198</volume>
<page-range>113500</page-range></nlm-citation>
</ref>
<ref id="B32">
<label>32</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Thompson]]></surname>
<given-names><![CDATA[SC]]></given-names>
</name>
<name>
<surname><![CDATA[Cheetham]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Baxi]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[The enablers, barriers and preferences of accessing radiation therapy facilities in the rural developed world - a systematic review]]></article-title>
<source><![CDATA[BMC Cancer]]></source>
<year>2017</year>
<volume>17</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>794</page-range></nlm-citation>
</ref>
<ref id="B33">
<label>33</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Song]]></surname>
<given-names><![CDATA[T]]></given-names>
</name>
<name>
<surname><![CDATA[Sura]]></surname>
<given-names><![CDATA[KT]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Achieving Equity in Transportation for Radiotherapy]]></article-title>
<source><![CDATA[Cureus]]></source>
<year>2024</year>
<volume>16</volume>
<numero>7</numero>
<issue>7</issue>
</nlm-citation>
</ref>
<ref id="B34">
<label>34</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Charlton]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Schlichting]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Chioreso]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Ward]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Vikas]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Challenges of Rural Cancer Care in the United States]]></article-title>
<source><![CDATA[Oncology (Williston Park)]]></source>
<year>2015</year>
<volume>29</volume>
<numero>9</numero>
<issue>9</issue>
<page-range>633-40</page-range></nlm-citation>
</ref>
<ref id="B35">
<label>35</label><nlm-citation citation-type="">
<collab>Cátedra de Oncología Clínica, Servicio de Oncología Clínica, Hospital de Clínicas, Facultad de Medicina, Universidad de la República</collab>
<source><![CDATA[Pautas de Oncología Médica para el Diagnóstico, Tratamiento Sistémico y Seguimiento]]></source>
<year>2023</year>
</nlm-citation>
</ref>
<ref id="B36">
<label>36</label><nlm-citation citation-type="book">
<source><![CDATA[PDQ Cancer Information Summaries]]></source>
<year>2024</year>
<publisher-loc><![CDATA[Bethesda ]]></publisher-loc>
<publisher-name><![CDATA[National Cancer Institute]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B37">
<label>37</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Della Valle]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Acevedo]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Comités de Tumores en Uruguay ¿Cuál es el estado de situación diez años después?]]></article-title>
<source><![CDATA[Revista Médica del Uruguay]]></source>
<year>2012</year>
<volume>28</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>262-5</page-range></nlm-citation>
</ref>
<ref id="B38">
<label>38</label><nlm-citation citation-type="book">
<collab>Organización Mundial de la Salud</collab>
<source><![CDATA[Control de cáncer: Aplicación de los conocimientos. Guía de la OMS para desarrollar programas eficaces. Cuidados paliativos. Ginebra,]]></source>
<year>2007</year>
<publisher-loc><![CDATA[Suiza ]]></publisher-loc>
<publisher-name><![CDATA[OMS]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B39">
<label>39</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[McAteer]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Wellbery]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Palliative care benefits, barriers, and best practices]]></article-title>
<source><![CDATA[Am Fam Physician]]></source>
<year>2013</year>
<volume>88</volume>
<numero>12</numero>
<issue>12</issue>
<page-range>807-13</page-range></nlm-citation>
</ref>
<ref id="B40">
<label>40</label><nlm-citation citation-type="book">
<source><![CDATA[Ordenanza Ministerial Nº 1695/019: Lineamientos para el Desarrollo de Cuidados Paliativos en Uruguay]]></source>
<year>2019</year>
<publisher-name><![CDATA[Ministerio de Salud Pública]]></publisher-name>
</nlm-citation>
</ref>
</ref-list>
</back>
</article>
